Clinical trial
A Window Trial of Vorinostat in Patients With Ductal Carcinoma in Situ (DCIS) of the Breast
NCT00788112 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Window Trial of Vorinostat in Patients With Ductal Carcinoma in Situ (DCIS) of the Breast
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- August 11, 2015
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer